Your browser doesn't support javascript.
loading
Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification.
Noro, R; Honda, K; Tsuta, K; Ishii, G; Maeshima, A M; Miura, N; Furuta, K; Shibata, T; Tsuda, H; Ochiai, A; Sakuma, T; Nishijima, N; Gemma, A; Asamura, H; Nagai, K; Yamada, T.
Afiliación
  • Noro R; Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, Tokyo; Department of Internal Medicine, Division of Pulmonary Medicine, Infectious Diseases and Oncology, Nippon Medical School, Tokyo.
  • Honda K; Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, Tokyo.
  • Tsuta K; Pathology and Clinical Laboratory Division, National Cancer Center Hospital, Tokyo.
  • Ishii G; Department of Pathology, Research Center for Innovative Oncology, National Cancer Center Research Institute, Tokyo.
  • Maeshima AM; Pathology and Clinical Laboratory Division, National Cancer Center Hospital, Tokyo.
  • Miura N; Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, Tokyo.
  • Furuta K; Division of Clinical Laboratories, National Cancer Center Hospital, Tokyo.
  • Shibata T; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo.
  • Tsuda H; Pathology and Clinical Laboratory Division, National Cancer Center Hospital, Tokyo.
  • Ochiai A; Department of Pathology, Research Center for Innovative Oncology, National Cancer Center Research Institute, Tokyo.
  • Sakuma T; Mitsui Knowledge Industry, Tokyo.
  • Nishijima N; Department of Internal Medicine, Division of Pulmonary Medicine, Infectious Diseases and Oncology, Nippon Medical School, Tokyo.
  • Gemma A; Department of Internal Medicine, Division of Pulmonary Medicine, Infectious Diseases and Oncology, Nippon Medical School, Tokyo.
  • Asamura H; Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo.
  • Nagai K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Yamada T; Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, Tokyo. Electronic address: tyamada@ncc.go.jp.
Ann Oncol ; 24(10): 2594-2600, 2013 Oct.
Article en En | MEDLINE | ID: mdl-23899839
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Actinina / Adenocarcinoma / Carcinoma de Pulmón de Células no Pequeñas / Dosificación de Gen / Variaciones en el Número de Copia de ADN / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2013 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Actinina / Adenocarcinoma / Carcinoma de Pulmón de Células no Pequeñas / Dosificación de Gen / Variaciones en el Número de Copia de ADN / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2013 Tipo del documento: Article Pais de publicación: Reino Unido